Chutes & Ladders—Novartis’ Sandoz chief exits, fueling spinoff and sale rumors

Novartis’ Sandoz chief Francis exits, fueling spinoff and sale rumors; NCI Director Ned Sharpless to be interim FDA commissioner; C4 poaches new CMO; and Karuna hires another ex-Lilly scientist. Those moves plus more hirings, firings and retirings throughout the industry.

READ  Antibiotic Nasal Gel for Surgical Infections Cruises Through Phase I

Categories: Industry

Tagged as:

Leave a Reply